Research Conducted in this State

Research conducted in this State refers to qualified research activities physically performed within the geographical borders of New Jersey by employees or contractors to develop or improve products and processes. Under N.J.S.A. 54:10A-5.24, only expenditures tied to these specific in-state activities—including local wages, supplies consumed on-site, and New Jersey-based contract research—are eligible for the 10% tax credit.

The New Jersey Research and Development (R&D) Tax Credit serves as a cornerstone of the state’s economic strategy to incentivize innovation and retain high-growth technology and biotechnology firms. While the state credit is largely modeled after the federal credit for increasing research activities under Internal Revenue Code (I.R.C.) Section 41, the New Jersey Division of Taxation imposes a strict jurisdictional mandate. This mandate dictates that only expenses incurred for research activities performed physically within the state of New Jersey may be included in the credit calculation. This geographic tether ensures that the tax subsidy directly benefits the local economy, supports New Jersey-based labor, and utilizes the state’s extensive network of research universities and specialized facilities. Consequently, taxpayers must go beyond federal record-keeping requirements to delineate precisely where work was performed and where supplies were consumed, making the definition of “research conducted in this State” the most critical filter in the entire tax credit claim process.

Statutory Authority and Regulatory Framework

The primary legal authority for the New Jersey R&D Tax Credit is found in the Corporation Business Tax Act at N.J.S.A. 54:10A-5.24. This statute establishes the eligibility criteria, calculation methods, and carryover provisions for the credit. To provide practical application of these laws, the New Jersey Division of Taxation has promulgated regulations under N.J.A.C. 18:7-3.23 (applicable to periods before 2018) and N.J.A.C. 18:7-3.23A (applicable to periods on or after January 1, 2018).

The statutory language explicitly states that while federal terms such as “qualified research expenses,” “base amount,” and “basic research” are adopted, they are modified to “include only expenditures for research conducted in this State”. This statutory restriction overrides any broader federal definitions that might allow for research conducted elsewhere in the United States. For taxpayers, this means that even if an activity meets the federal “Four-Part Test” for R&D, it is effectively disqualified for New Jersey purposes the moment the activity crosses state lines.

The Evolution of the Regulatory Standards

The transition in 2018 was significant for New Jersey taxpayers. Before this date, New Jersey maintained a more distinct calculation method that often required separate “start-up” calculations if historical data was unavailable. Post-2018, the state significantly coupled its methodology with the federal Alternative Simplified Credit (ASC) and Regular Credit methods, while maintaining the non-negotiable geographic restriction. This coupling reduces the administrative burden of calculating the credit but increases the importance of precise allocation between New Jersey and “everywhere” expenses.

Defining the Scope of Qualified In-State Activities

To understand what constitutes “research conducted in this State,” one must examine the specific categories of expenditures that the New Jersey Division of Taxation recognizes as being intrinsically tied to the state’s geography. These categories mirror I.R.C. Section 41 but are viewed through a localized lens.

Qualified Research Wages and the Physical Labor Requirement

Wages represent the largest component of most R&D tax credit claims. In New Jersey, qualified wages include salaries, bonuses, and even stock options paid to employees for “qualified services”. However, the “conducted in this State” requirement applies to the physical location of the employee at the time the work is performed.

Under N.J.A.C. 18:7-3.23A(d), a credit may be claimed only for research activities performed in New Jersey. This creates a high evidentiary bar for companies with employees who split their time between a New Jersey office and a location in another state. If a lead scientist at a Princeton-based pharmaceutical firm works from home in Pennsylvania three days a week, only the 40% of their time spent physically in the Princeton laboratory is eligible for the New Jersey credit, even if 100% of their work qualifies for the federal credit.

Expenditure Type	Federal Qualification (I.R.C. § 41)	New Jersey Qualification (N.J.S.A. 54:10A-5.24)
In-House Wages	Performed within the U.S.	Performed physically within NJ borders.
Supplies	Used in U.S. experimentation.	Consumed physically in NJ experimentation.
Contract Research	Performed by U.S. 3rd parties (65%).	Performed by NJ 3rd parties (65%).
Basic Research	Paid to U.S. qualified organizations.	Paid to NJ qualified organizations/universities.
Computer Rentals	Used in U.S. research.	Physically located or used directly in NJ.

Supplies Consumed in Local Experimentation

The cost of supplies used in the conduct of qualified research—such as laboratory chemicals, prototype materials, and testing reagents—is eligible if the supplies are used in research conducted in New Jersey. The Division of Taxation interprets this as the location where the experimentation occurs. If materials are purchased from a New Jersey vendor but shipped to a research facility in North Carolina, those expenses are not eligible for the New Jersey credit. Conversely, materials purchased from an out-of-state vendor but consumed in a New Jersey lab qualify as in-state expenditures.

Contract Research and the Third-Party Nexus

Contract research expenses, generally limited to 65% of the actual payments made to third parties, must be for research performed in New Jersey. This necessitates that the taxpayer verify the performance location of their contractors. In many instances, large contract research organizations (CROs) operate across multiple states. A taxpayer hiring a CRO must obtain documentation—often in the form of a statement or contract rider—specifying that the research services were performed at the contractor’s New Jersey site.

Basic Research Payments to New Jersey Institutions

Basic research payments involve payments to qualified organizations, such as universities or scientific research organizations, for original investigation to advance scientific knowledge without a specific commercial objective. For New Jersey purposes, the recipient must be a “qualified organization” within the state. The credit explicitly includes payments to New Jersey universities (e.g., Rutgers, Princeton, NJIT) or New Jersey-based energy research consortia for research conducted in the state.

Administrative Guidance: Technical Bulletin TB-114

Technical Bulletin TB-114, most recently updated in November 2025, serves as the primary guidance document from the New Jersey Division of Taxation regarding the R&D credit. It clarifies several complex areas of the law, particularly concerning how the state handles federal tax changes and the unique filing requirements of different business entities.

Interaction with Federal I.R.C. Section 174 Amortization

A major point of recent concern for tax professionals has been the federal requirement under the Tax Cuts and Jobs Act (TCJA) to amortize R&D expenses over five years (for domestic research) or fifteen years (for foreign research) rather than expensing them immediately. New Jersey’s TB-114 provides critical guidance here: for privilege periods beginning on or after January 1, 2022, New Jersey allows for the immediate deduction of these expenditures for CBT purposes, even if they must be amortized federally.

However, this decoupling applies to the deduction of the expense. For the credit calculation, the state remains coupled to federal definitions. This creates a scenario where a taxpayer can deduct 100% of their NJ QREs in the current year for CBT purposes while simultaneously using those same QREs to calculate a 10% tax credit. This “same-year deduction” rule is a significant advantage of the New Jersey tax code compared to other states that followed the federal amortization schedule.

Method Consistency Requirements

TB-114 emphasizes that since 2018, taxpayers must use the same method—either the Regular Credit method or the ASC method—for their New Jersey R&D credit as they do for their federal credit.

• Regular Credit Method: Focuses on the incremental increase over a historical base period (often involving gross receipts from the 1980s or early years of the business).
• ASC Method: Uses a base amount equal to 50% of the average QREs from the three prior years, making it much easier for startups or companies with fluctuating research budgets.

The choice of method must be consistent. If a taxpayer amends their federal return to change their R&D credit method, they must also file an amended New Jersey CBT return to reflect that change.

Handling Hard-to-Quantify Research Expenses

In the modern corporate environment, research is often a collaborative effort spanning multiple jurisdictions. Recognizing that it is sometimes “impossible or impractical” to track every minute of an employee’s time or every gram of material used by location, N.J.A.C. 18:7-3.23A(j) provides a standardized fallback method for multi-state apportionment.

The Three-Factor Apportionment Fraction

If a taxpayer conducts research both within and outside New Jersey and cannot precisely determine the in-state expenses, they may calculate the New Jersey QREs using a three-factor fraction. This fraction is the average of three ratios comparing New Jersey research assets to total research assets.

Factor	Numerator (New Jersey)	Denominator (Everywhere)
Property Factor	Average value of real and tangible property used in NJ research.	Average value of all such property used in research everywhere.
Payroll Factor	Compensation for research services performed in New Jersey.	Total research compensation everywhere.
Receipts Factor	Gross receipts from research conducted in New Jersey.	Total research-related gross receipts everywhere.

This apportionment method provides a “safe harbor” for larger corporations, but the Division of Taxation maintains the right to demand actual records if they believe a more accurate determination is possible. For a combined group, this three-factor formula is applied to the group’s aggregate research activities to determine the New Jersey-specific portion.

Entity-Specific Nuances and Limitations

The New Jersey R&D credit does not apply uniformly to all business types. The Division of Taxation provides specific rules for S corporations, partnerships, and combined groups that differ sharply from federal treatment.

S Corporations and the Pass-Through Prohibition

Unlike the federal R&D credit, which typically passes through to S corporation shareholders on their personal tax returns, the New Jersey R&D credit is strictly an entity-level credit for S corporations.

• The credit can only be used to offset the S corporation’s own CBT liability (such as the tax on built-in gains or the minimum tax).
• It cannot be passed through to individual shareholders via Schedule K-1 for use against New Jersey Gross Income Tax.
• Unused credits are carried forward by the S corporation itself, which may be beneficial if the entity later elects C corporation status or joins a combined group.

Partnerships and Corporate Partners

Partnerships themselves do not claim the R&D credit because they are not CBT taxpayers. Instead, the partnership calculates its New Jersey QREs and allocates them to its corporate partners. Each corporate partner then claims its distributive share of the credit on its own CBT-100 or CBT-100U return using Form 306.

Combined Groups and Mandatory Reporting

Since July 31, 2019, New Jersey has required most related corporations to file as a combined group. In this context:

• Credits are generally calculated for each member but may be shared among the taxable members of the group.
• The credit cannot reduce any individual member’s tax liability below its statutory minimum.
• If a member with R&D credits leaves the group, the credits typically stay with that specific entity unless other rules apply under TB-114.

Special Provisions for High-Growth Sectors

To support New Jersey’s “Innovation Economy,” the state offers two primary enhancements for technology and biotechnology firms that meet specific criteria.

The 15-Year Extended Carryforward

While the standard carryforward for unused R&D credits is seven privilege periods, a 15-year carryforward is available for firms conducting research in specific high-tech fields. This is particularly valuable for life sciences companies that may have years of research expenses before bringing a product to market.

Eligible Field	Description
Advanced Computing	Development of hardware, software, and systems.
Advanced Materials	Synthesis of new chemicals or substances.
Biotechnology	Biological and medical research involving DNA or cellular processes.
Electronic Devices	Innovation in semiconductors and hardware components.
Environmental Tech	Waste reduction, energy efficiency, and remediation.
Medical Devices	Development of diagnostic and therapeutic equipment.

The NJEDA Credit Transfer (Sale) Program

Perhaps the most unique feature of the New Jersey innovation ecosystem is the Technology Business Tax Certificate Transfer Program. Unprofitable technology and biotechnology companies with fewer than 225 U.S. employees can sell their unused R&D credits (and NOLs) for cash.

• Valuation: Credits must be sold for at least 80% of their value.
• Cap: Firms can receive up to $20 million in lifetime benefits from this program.
• Impact: In 2024, approximately $30 million in R&D credits were sold through this mechanism, providing immediate liquidity to startups that would otherwise have no use for a non-refundable tax credit.

Example of Research Location Apportionment

To demonstrate how these rules apply in a real-world business scenario, consider “AeroSim NJ,” a fictional aerospace engineering firm based in Newark with a satellite testing site in Pennsylvania.

AeroSim NJ 2024 Research Data:

• Total Employee Wages (All R&D): $2,000,000.
• Personnel Distribution: 75% of research hours are performed at the Newark headquarters; 25% are performed at the Pennsylvania testing site.
• Contract Research: $500,000 paid to a New Jersey-based engineering firm; $200,000 paid to a California-based software consultant.
• Supplies: $100,000 of composite materials used in Newark; $50,000 used in Pennsylvania.

Step 1: Calculate New Jersey QREs

• NJ Wages: 75% of $2,000,000 = $1,500,000.
• NJ Contract Research: 65% of the $500,000 paid to the NJ-based firm = $325,000. The California payment ($200,000) is entirely excluded for New Jersey purposes.
• NJ Supplies: Only the $100,000 used in Newark qualifies.
• Total NJ QREs: $1,500,000 + $325,000 + $100,000 = $1,925,000.

Step 2: Apply the Credit Calculation (Assuming ASC Method)

If AeroSim NJ had average NJ QREs of $1,200,000 over the three prior years:

• Base Amount: 50% of $1,200,000 = $600,000.
• Excess QREs: $1,925,000 – $600,000 = $1,325,000.
• New Jersey R&D Credit: 10% of $1,325,000 = $132,500.

If AeroSim NJ is an unprofitable startup in the “Advanced Materials” field, it could apply to the NJEDA to sell this $132,500 credit for at least $106,000 in cash (80% of value) to fund its next phase of research.

The Remote Work Challenge and the Convenience of Employer Rule

The post-pandemic shift toward remote work has complicated the “conducted in this State” requirement. In July 2023, New Jersey enacted P.L. 2023, c. 125, which adopted a “Convenience of the Employer” rule for nonresidents from certain states like New York and Delaware. While this rule primarily affects individual income tax sourcing, it has indirect implications for the R&D credit wage base.

The Division of Taxation maintains that for R&D purposes, the wage must be for services performed in New Jersey. If a researcher is working remotely for their own convenience from an out-of-state home, those wages typically do not qualify as “research conducted in this State,” even if the employer is located in New Jersey and pays New Jersey payroll taxes on those wages. Taxpayers must be careful not to conflate “New Jersey source income” for withholding purposes with “research conducted in this State” for R&D credit purposes.

Statistical Overview of the R&D Credit in New Jersey

The New Jersey R&D tax credit is a significant fiscal commitment by the state. While specific annual reports for the R&D credit alone are sometimes consolidated with other CBT data, the impact of innovation programs is clear from NJEDA assessments.

Metric	Detail/Value
Annual Credit Sales (NJEDA)	~$30 million to ~$75 million authorized annually.
Program Recipients (NOL/R&D)	Over 589 emerging tech companies supported since 1999.
Economic Impact	$28.1 billion in direct/indirect impact from supported firms in 2024.
Job Creation	~31,200 workers employed by program recipients.
Fiscal Return	$2 in state tax revenue generated for every $1 in credits/benefits.

Despite these successes, the state has recently seen volatility in business tax revenues. In August 2025, CBT collections fell by over 50% year-to-date, reflecting broader economic shifts and the impact of federal tax law changes on corporate behavior. This underscores the importance of the R&D credit as a tool to keep the “economic engine” of the state running by incentivizing long-term investment rather than short-term profitability.

Audit and Documentation Best Practices

Because the New Jersey R&D credit is so heavily dependent on geography, it is a frequent target for detailed audits by the Division of Taxation. A successful defense of a credit claim depends almost entirely on the quality of documentation maintained at the time the research was performed.

Essential Records for In-State Verification

• Contemporaneous Location Records: Time-tracking data that identifies the physical location (e.g., specific lab or office) where each researcher worked.
• Project Lists: A detailed list of all R&D projects, including the specific New Jersey facility where each project was headquartered.
• Supply Invoices and Consumption Logs: Evidence that supplies were delivered to and consumed at a New Jersey address.
• Contractor Attestations: Written statements from third-party contractors confirming that their services were performed in New Jersey.
• Federal Forms: A complete copy of federal Form 6765 must be kept, as any adjustment by the IRS to the federal credit must be reported to New Jersey within 90 days, potentially triggering a state re-calculation.

Final Thoughts

The “research conducted in this State” requirement is the defining characteristic of the New Jersey R&D Tax Credit. It transforms a standard federal tax benefit into a powerful tool for local industrial policy, ensuring that every dollar of tax relief provided by the state is earned through physical investment in New Jersey’s borders. By coupling with federal methodologies while decoupling from restrictive federal expensing rules, New Jersey has created a highly competitive environment for innovation. However, the complexity of this jurisdictional mandate—especially in the context of remote work, multi-state contract research, and combined group filing—requires a sophisticated approach to tax planning and documentation. For businesses that can master these rules, the 10% credit, combined with unique monetization opportunities through the NJEDA, remains one of the most effective ways to leverage the state’s world-class scientific and technological infrastructure. As the state continues to refine its guidance through Technical Bulletins like TB-114, the focus on physical presence will likely remain the touchstone for all future advancements in New Jersey’s innovation economy.